Literature DB >> 2408147

Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C.

M R Smith1, Y L Liu, H Kim, S G Rhee, H F Kung.   

Abstract

Several immunologically distinct isozymes of inositol phospholipid-specific phospholipase C (PLC) have been purified from bovine brain. Murine NIH 3T3 fibroblasts were found to express PLC-gamma, but the expression of PLC-beta was barely detectable by radioimmunoassay or protein immunoblot. A mixture of monoclonal antibodies was identified that neutralizes the biological activity of both endogenous and injected purified PLC-gamma. When co-injected with oncogenic Ras protein or PLC-gamma, this mixture of antibodies inhibited the induction of DNA synthesis that characteristically results from the injection of these proteins into quiescent 3T3 cells. However, when oncogenic Ras protein or PLC-gamma was co-injected with a neutralizing monoclonal antibody to Ras, only the DNA synthesis induced by the Ras protein was inhibited--that induced by PLC was unaffected. These results suggest that the Ras protein is an upstream effector of PLC activity in phosphoinositide-specific signal transduction and that PLC-gamma activity is necessary for Ras-mediated induction of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2408147     DOI: 10.1126/science.2408147

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  24 in total

1.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 2.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 3.  Mitogenic pathways regulated by G protein oncogenes.

Authors:  S K Gupta; C Gallego; G L Johnson
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

4.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

Authors:  F Fazioli; U H Kim; S G Rhee; C J Molloy; O Segatto; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

5.  Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Chiara Puggioni; Carlo Della Rocca; Rita Businaro
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

Review 6.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C.

Authors:  D L Chung; P W Brandt-Rauf; I B Weinstein; S Nishimura; Z Yamaizumi; R B Murphy; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C.

Authors:  Simge Akbulut; Alagarsamy L Reddi; Priya Aggarwal; Charuta Ambardekar; Barbara Canciani; Marianne K H Kim; Laura Hix; Tomas Vilimas; Jacqueline Mason; M Albert Basson; Matthew Lovatt; Jonathan Powell; Samuel Collins; Steven Quatela; Mark Phillips; Jonathan D Licht
Journal:  Mol Biol Cell       Date:  2010-08-18       Impact factor: 4.138

9.  p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts.

Authors:  A Krook; M J Rapoport; S Anderson; H Pross; Y C Zhou; D T Denhardt; T L Delovitch; T Haliotis
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Immunocytochemical localization of phospholipase C-gamma in rat embryo fibroblasts.

Authors:  K McBride; S G Rhee; S Jaken
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.